Cash · 2011–2025
Sarepta Therapeutics cash
$801M−27.4% · FY2025
Sarepta Therapeutics (SRPT) reported $801M in cash for fiscal 2025, −27.4% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $801M | −27.4% | Open → |
| FY20242024-12-31 | $1.1B | +157.5% | Open → |
| FY20232023-12-31 | $428M | −55.7% | Open → |
| FY20222022-12-31 | $967M | −54.3% | Open → |
| FY20212021-12-31 | $2.1B | +40.8% | Open → |
| FY20202020-12-31 | $1.5B | +79.9% | Open → |
| FY20192019-12-31 | $835M | +125.2% | Open → |
| FY20182018-12-31 | $371M | −38.2% | Open → |
| FY20172017-12-31 | $600M | +389.9% | Open → |
| FY20162016-12-31 | $122M | +52.4% | Open → |
| FY20152015-12-31 | $80.3M | +9.2% | Open → |
| FY20142014-12-31 | $73.6M | −71.4% | Open → |
| FY20132013-12-31 | $257M | +36.9% | Open → |
| FY20122012-12-31 | $188M | +370.3% | Open → |
| FY20112011-12-31 | $39.9M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +23.9%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Sarepta Therapeutics cash |url=https://companiesranked.com/en/company/sarepta-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Sarepta Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/sarepta-therapeutics/cash-on-handBibTeX
@misc{companiesranked-en-company-sarepta-therapeutics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Sarepta Therapeutics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sarepta-therapeutics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-335003 · August 5, 2026
{{cite web |title=Sarepta Therapeutics cash — 10-Q (0001193125-26-335003) |url=https://www.sec.gov/Archives/edgar/data/873303/000119312526335003/srpt-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.